Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02367859Phase 2Completed
Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma
AmeloblastomaBRAF Gene Mutation
PrincipalinvestigatorStart date: 2017-07-17
NCT01823679Phase 2Terminated
Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin
Recurrent Skin CancerSquamous Cell Carcinoma of the Skin
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Gulalai Hanan, MD

Department of Oncology, Vejle Hospital, Denmark

Related
1 trials

Shared therapeutic areas:

Cutaneous Squamous Cell Carcinoma
Similarity Score8%

Lara Dunn, MD

Memorial Sloan Kettering Cancer Center

Related
3 trials

Shared therapeutic areas:

Cutaneous Squamous Cell Carcinoma
Similarity Score8%

Nina Bhardwaj, MD, PhD

Icahn School of Medicine at Mount Sinai

Related
8 trials

Shared therapeutic areas:

Cutaneous Squamous Cell Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Anthony Kong

Clinical reader and honorary NHS consultant in clinical oncology

Related
2 trials

Shared therapeutic areas:

Cutaneous Squamous Cell Carcinoma
Similarity Score8%

Marie BEYLOT-BARRY, MD, PhD

University Hospital, Bordeaux

Related
3 trials

Shared therapeutic areas:

Cutaneous Squamous Cell Carcinoma
Similarity Score8%

Peter Kanetsky, PhD, MPH

Moffitt Cancer Center

Related
2 trials

Shared therapeutic areas:

Cutaneous Squamous Cell Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Ali Bekyashev, MD, professor

Blokhin's Russian Cancer Research Center

Related
2 trials

Shared therapeutic areas:

BRAF Gene Mutation
Similarity Score8%

TAREK ABDELBARY, Lecturer

Faculty of Dentistry, Minia University

Related
2 trials

Shared therapeutic areas:

Ameloblastoma
Similarity Score8%

Vincent Ma, MD

University of Wisconsin, Madison

Related
3 trials

Shared therapeutic areas:

Cutaneous Squamous Cell Carcinoma
Similarity Score8%

Eric Sherman, MD

Memorial Sloan Kettering Cancer Center

Related
4 trials

Shared therapeutic areas:

BRAF Gene Mutation
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02367859Phase 2PrincipalInvestigator

Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma

AmeloblastomaBRAF Gene Mutation
Completed
NCT01823679Phase 2PrincipalInvestigator

Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin

Recurrent Skin CancerSquamous Cell Carcinoma of the Skin
Terminated

All 2 trials loaded